DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
|Docket||Start Trial||Date Filed||2019-10-30|
|Court||District Court, E.D. New York||Date Terminated|
|Cause||35:271 Patent Infringement||Assigned To||Joan Marie Azrack|
|Jury Demand||Plaintiff||Referred To||Steven I. Lock|
|Patents||10,328,031; 10,328,103; 7,202,075; 9,399,023; 9,399,040; 9,950,112|
|Link to Docket||External link to docket|
Small Molecule Drugs cited in Signify North America Corporation v. Satco Products, Inc.
Biologic Drugs cited in Signify North America Corporation v. Satco Products, Inc.
|Date Filed||Document No.||Description||Snippet||Link To Document|
|2020-05-19||61||Compel||seven Patents-in-Suit and has already contended (unsuccessfully) that the ’399, ’554, and ’328 patents…102, 103, and/or 112.” See Dkt. 10 (counterclaims) at ¶¶ 19, 23, 27, 31, 35, 40, 44 (emphasis added). In…been on notice of its infringement of four of the Patents-in-Suit since November 2014, when Signify provided… to serve its invalidity contentions for these patents within the timeframe provided in the Local Rules…Satco has already counterclaimed that all of the Patents-in-Suit are invalid. For example, Satco filed counterclaims||External link to document|
|>Date Filed||>Document No.||>Description||>Snippet||>Link To Document|